Clinical Trial Update: Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

View source ↗

Summary

An observational, real-world study completed to evaluate how atypical antipsychotics are allocated in the acute inpatient management of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Atypical antipsychotics (class)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED